| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c12996bec666beffcba7b5f52331551c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d6eb785a13032f52d1f7f654acac96d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
2007-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0fd14aaa4c62409fd8962d3b1344a70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3de4a36c5354849d0901cbefb161e783 |
| publicationDate |
2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2331501-B1 |
| titleOfInvention |
SOLID PHARMACEUTICAL COMPOSITION OF DIDANOSINE. |
| abstract |
Solid pharmaceutical composition ofndidanosinen n n The present invention relates to a newnsolid pharmaceutical composition of didanosine comprisingndidanosine crystals with an average particle sizenbetween 50 and 500 microns, covered by a layer of anenteric coating The pharmaceutical composition of the inventionnit can be prepared by a simple procedure, which comprises thencoating of didanosine crystals with an enteric layer.nSaid composition and presents a good stability of the principlenactive as well as an appropriate release in the conditionsnpresent in the upper part of the gastrointestinal tract. I also knownrefers to the use of said composition for the preparation of formsnsolid pharmaceuticals of didanosine for administration via routenoral. The invention also relates to tablets and capsules ofnhard gelatin containing said composition. |
| priorityDate |
2007-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |